News25/Ratings1
News · 26 weeks48+67%
2026-03-012026-08-23
Mix1590d
- SEC Filings4(27%)
- Other4(27%)
- Insider3(20%)
- Leadership2(13%)
- Earnings2(13%)
Latest news
25 items- INSIDERDirector Dimaio John Michael was granted 35,000 shares, increasing direct ownership by 1% to 2,766,847 units (SEC Form 4)4 - Spectral AI, Inc. (0001833498) (Issuer)
- SECSEC Form SCHEDULE 13G filed by Spectral AI Inc.SCHEDULE 13G - Spectral AI, Inc. (0001833498) (Subject)
- SECSpectral AI Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Spectral AI, Inc. (0001833498) (Filer)
- PRSpectral AI Announces 2026 Second Quarter Financial ResultsCompany Continues to Advance Towards First Commercial Sales of the DeepView® System for Burn Indication Strong Cash Position of $14.0 Million at June 30, 2026 DALLAS, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the second quarter ended June 30, 2026 ("Q2 2026"). "Spectral AI has entered the second half of 2026 with tremendous momentum and a clear sense of purpose," said Vincent Capone, Chief Executive Officer of Spectral AI. "The receipt of De Novo clearance from the
- SECSEC Form 10-Q filed by Spectral AI Inc.10-Q - Spectral AI, Inc. (0001833498) (Filer)
- PRSpectral AI Schedules 2026 Second Quarter Financial Results and Conference CallDALLAS, July 29, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the second quarter ended June 30, 2026 on Tuesday, August 11, 2026, after the close of the Nasdaq stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time on the same day to discuss its financial results. Investors interested in participating in the live call can dial into the conference call as follows: 833-890-6620 – U.S.412-564-3789 – International In ad
- SECSpectral AI Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Spectral AI, Inc. (0001833498) (Filer)
- PRSpectral AI Names Darcy Bajko Chief Commercial Officer to Lead Global Sales Launch of FDA-Cleared DeepView® System for Burn IndicationDALLAS, July 08, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the appointment of Darcy Bajko as Chief Commercial Officer, effective July 31, 2026. Ms. Bajko will lead the commercial functions in support of Spectral AI’s global launch of its DeepView® System for burn indication, which was granted De Novo Classification by the U.S. Food and Drug Administration (FDA) in May 2026. "Darcy’s appointment further strengthens our executive team and represents an important step for Spectral AI as we pivot
- INSIDERDirector Dimaio John Michael was granted 44,000 shares, increasing direct ownership by 2% to 2,731,847 units (SEC Form 4)4 - Spectral AI, Inc. (0001833498) (Issuer)
- PRDeepView® System Highlighted at the 2026 British Burn Association Annual ConferenceDALLAS, June 25, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today reflected on its successful participation at the British Burn Association (BBA) Annual Conference, held on June 17th – 19th at the Nottingham Trent University, Nottingham, England. The Company’s DeepView® System was on display and was the subject of multiple podium and poster presentations during the conference, highlighting its contributions to advancing burn care through advanced diagnostic analysis across the globe. The presentation fr
- PRSpectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness MonthDALLAS, June 12, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, is joining the American Board of Wound Management (ABWM) Foundation in celebrating the 10th Annual Wound Healing Awareness Month. In this milestone year, during the month of June the ABWM Foundation will continue its mission of raising awareness, empowering certified wound care specialists, and transforming lives. "Wound Healing Awareness Month is an important reminder that patients living with painful, sometimes complex burn wounds require a timely
- PRSpectral AI to Participate in 2026 British Burn Association Annual ConferenceDALLAS, June 11, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced its participation in the upcoming British Burn Association ("BBA") Annual Meeting, being held June 17-19, 2026 at the Nottingham Trent University, Nottingham, England. The Company's DeepView® System will be on display at Stand #22 and will be the subject of multiple podium and poster presentations during the conference. This innovative, first-of-its-kind burn wound assessment technology was granted De Novo Classification by the U.S
- SECSpectral AI Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Spectral AI, Inc. (0001833498) (Filer)
- INSIDERDirector Dimaio John Michael was granted 17,500 shares, increasing direct ownership by 0.66% to 2,687,847 units (SEC Form 4)4 - Spectral AI, Inc. (0001833498) (Issuer)
- PRSpectral AI Announces Voting Results of Annual Meeting of StockholdersDALLAS, June 01, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced results from its 2026 Annual Meeting of Stockholders, held on May 29, 2026. The Company also provided an overview of its accomplishments to date and targeted milestones for 2026 following the receipt of De Novo Classification for its DeepView® System from the U.S. Food and Drug Administration ("FDA"). 2026 Annual Meeting of Stockholders A total of 17,267,570 shares representing 54.3% of the Company's total shares outstanding were re
- INSIDERDirector Dimaio John Michael was granted 32,233 shares, increasing direct ownership by 1% to 2,670,347 units (SEC Form 4)4 - Spectral AI, Inc. (0001833498) (Issuer)
- SECSpectral AI Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Spectral AI, Inc. (0001833498) (Filer)
- PRSpectral AI Receives FDA De Novo Clearance for DeepView® System for Burn IndicationDALLAS, May 26, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that the U.S. Food and Drug Administration (FDA) granted De Novo Classification for its DeepView® System. With this classification, Spectral AI is authorized to commence commercial distribution activities in the United States. The DeepView System is intended for use in burn care in various settings, including burn centers, trauma centers, and emergency departments. "We are pleased that the FDA has recognized our novel technology. I a
- INSIDERDirector Sadagopan Deepak was granted 25,000 shares (SEC Form 4)4 - Spectral AI, Inc. (0001833498) (Issuer)
- INSIDERDirector Cotton Richard John was granted 14,700 shares, increasing direct ownership by 15% to 111,477 units (SEC Form 4)4 - Spectral AI, Inc. (0001833498) (Issuer)
- INSIDERDirector Dimaio John Michael was granted 26,887 shares, increasing direct ownership by 1% to 2,638,114 units (SEC Form 4)4 - Spectral AI, Inc. (0001833498) (Issuer)
- PRReal-Time Intoxication Detection Platforms Target Expanding Multibillion-Dollar Healthcare OpportunitiesAUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: For decades, reliably identifying drug and alcohol impairment has been a persistent problem across industries, from traffic enforcement and occupational safety to clinical medicine and public health. Conventional tools such as breathalyzers, blood draws and urine tests are hampered by their intrusiveness, slow turnaround times or inability to capture real-time impairment, especially when multiple substances are involved. As substance-use patterns shift and the broader societal costs of intoxication continue to mount, the pressure to develop faster, less invasive, and more scalable detection methods is intensifyi
- PRSpectral AI Announces 2026 First Quarter Financial ResultsDevelopment Work for DeepView® Systems Continues with Support of Recently Awarded $31.7 Million of Funding from BARDA Reiterates Annual Revenues Guidance DALLAS, May 12, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the first quarter ended March 31, 2026. "Our results for the 2026 first quarter reflected the progress we have made in developing our DeepView® System for burn indication under the base phase of our Project BioShield Contract with BARDA," said Vincent Capone, Chief
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Spectral AI Inc.SCHEDULE 13G/A - Spectral AI, Inc. (0001833498) (Subject)
- PRSpectral AI Wins Small Business Innovator Award at Inaugural Texas Innovation ConferenceDALLAS, April 30, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it has received the "Small Business Innovator Award" at the inaugural Texas Innovation Conference, held on April 22-23, 2026 at the campus of Texas Christian University. The conference highlighted organizations and thought leaders that are turning research into real-world results, bringing together a select group of high-impact innovators, including startups, researchers, and ecosystem leaders. The Texas Innovation Awards ceremo
MDAI FAQ
6 questionsWhere does MDAI stock trade?
Spectral AI Inc. (MDAI) is listed on NASDAQ.What sector and industry is MDAI in?
Spectral AI Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did Spectral AI Inc. go public?
Spectral AI Inc. (MDAI) completed its IPO in 2021.What are analysts saying about MDAI?
Spectral AI Inc. has had 1 recent analyst action on file. The most recent action was from BTIG Research: Buy with a $400.00 price target on 2024-01-23. Recent price targets cluster around $400.00.What companies are similar to MDAI?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare MDAI side-by-side with any of them on Quantisnow.How can I track MDAI on Quantisnow?
Quantisnow aggregates Spectral AI Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MDAI to receive live email and push alerts on every new disclosure.